What information must be included on a new prescription for a controlled substance in Alaska?

The correct answer is grounded in the regulations governing the prescription of controlled substances. In Alaska, a new prescription for a controlled substance must include comprehensive identifying information to ensure safety, proper dispensing, and regulatory compliance. The inclusion of the patient’s name and address allows for accurate identification and contact in case there are issues or questions regarding the prescription.

The date is critical for establishing the validity of the prescription, particularly with controlled substances that have refilling limitations and expiration dates. The drug name, strength, and quantity specified ensure that the pharmacy dispenses the correct medication and dosage, helping to prevent medication errors and potential misuse. Furthermore, clear directions for use are essential for patient compliance and safety.

The requirement for the prescriber’s information, such as their name and DEA number, establishes the authority under which the prescription is written, helps validate the prescription, and assists in monitoring controlled substances. This comprehensive approach helps balance patient access to necessary medications while also safeguarding against misuse and abuse.

In contrast, the other options lack critical elements that are mandated for a complete and lawful prescription for controlled substances. For example, omitting the date or prescriber’s information would compromise the validity and legality of the document, potentially leading to serious regulatory issues.